FDA Inspection 894199 — Xian Lijun Pharmaceutical Co., Ltd
The FDA completed an inspection of Xian Lijun Pharmaceutical Co., Ltd on August 22, 2014 in Xian. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- August 22, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xian (China)